HIQA Portal login page at portal.hiqa.ie
To log in to the HIQA Portal, follow these steps:
- Visit the HIQA Portal login page at https://portal.hiqa.ie/User/Login.
- Enter your Username and Password.
- Click the Sign In button.
If you encounter any issues, feel free to email po***********@hi**.ie. 😊🔐
The HIQA Portal serves as a platform for managing and accessing information related to health and social care services in Ireland. It allows authorized users to submit reports, access guidelines, and collaborate on quality assurance initiatives.
Authorized users within the health and social care sector in Ireland have access to the HIQA Portal. This includes professionals, administrators, and relevant stakeholders involved in quality assurance, reporting, and collaboration.
How do I request access to the HIQA Portal?
To request access to the HIQA Portal, follow these steps:
Register as a User:
- Visit the HIQA Portal.
- Click the Register Account button (for super-user accounts only).
- Complete the registration form.
- Your username and password will be issued once processed.
Log In:
- Visit the Portal.
- Enter your username and password.
- Click Sign In.
If you encounter any issues, email po***********@hi**.ie. 😊🔐
Also Read : TCD Blackboard Login
News
In Ireland, people aged 65 years and older can already receive the flu vaccine free of charge through the HSE Seasonal Influenza Vaccination Programme. Currently, a standard flu vaccine is used for this age group, with uptake of almost 77% among those aged 65 and older in the 2022-2023 flu season. Despite this, Irish data demonstrate that those aged 65 years and older are disproportionately affected by influenza, both in terms of morbidity and mortality, and that influenza can place a substantial burden on healthcare services every winter. In the 2022-2023 flu season, there were over 1,700 admissions to hospital for flu in this age group.
HIQA found that enhanced flu vaccines are safe and that a number of these vaccines are potentially more effective than standard vaccines. It also found that offering an enhanced vaccine, in place of a standard one, to those aged 65 years and older would be a good use of HSE resources. However, this finding was highly sensitive to the cost of the vaccines, making this a key consideration in any decision to fund enhanced flu vaccines and in price negotiations with vaccine manufacturers
